Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 2023-10-30 to 2024-05-08, indicating a recent change in the information related to Medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-09T01:56:13.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:35:50.000Z thumbnail image

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.